Skip to content
Research Article Open access CC BY 3.0

Prevalent Components of Metabolic Syndrome and Their Correlates in Apparently Healthy Individuals in Sub-saharan Africa

M. A. Charles-Davies, A. A. Fasanmade, J. A. Olaniyi, O. E. Oyewole, M. O. Owolabi, J. R. Adebusuyi, O. Hassan, M. T. Ajobo, M. O. Ebesunun, K. Adigun, K. S. Akinlade, U. A. Fabian, O. O. Popoola, S. K. Rahamon, W. Okunbolade, M. A. Ogunlakin, O. G. Arinola, E. O. Agbedana

International Journal of TROPICAL DISEASE & Health · pp. 740–752 · Published 15 May 2014

10.9734/IJTDH/2014/5864

Abstract

Aim: To assess the prevalent components of metabolic syndrome (MSC) and their related determinants of lipid metabolism in the Nigerian for early diagnosis, prevention and management of the metabolic syndrome (MS) and its associated diseases. Study Design: Cohort study. Place and Duration of Study: Department of Chemical Pathology, College of Medicine, University of Ibadan, Ibadan between March and August 2010. Methodology: 534 apparently healthy Nigerian traders aged 18–105 years were participants of a cohort study. The IDF (2005) criteria was used for MS diagnosis. Anthropometric indices and blood pressure (BP) were obtained by standard methods. Fasting plasma glucose, total cholesterol (TC), triglycerides (TG) and high density lipoprotein cholesterol (HDLC) were determined by enzymatic methods while low density lipoprotein cholesterol (LDLC) was calculated. Data analysed were statistically significant at P<0.05. Results: 60.1% of traders had 2 and 3MSC. 0.6%, 1.1% and 9.6% of traders had all 5MSC, ≥3MSC without elevated waist circumference (WC) and zero MSC respectively. Elevated WC, reduced HDLC and high BP were more frequent MSC representing 70.2%, 63.1% and 47.9% while FPG and TG were less frequent representing 11.2% and 2.2% of traders respectively. This pattern was similar in MS and non-MS groups. 25.3% of males and only 2.2% of females had no MSC. Reduced HDLC and elevated WC were the most frequent MSC in males and females respectively. All metabolic risk factors (MRF) except TC were significantly different in comparison between MS and non-MS groups as well as among traders with 0-5 MSC. WHR was the only parameter that correlated significantly with all MRF. Conclusion: Elevated waist circumference, reduced high density lipoprotein cholesterol, and high blood pressure may be prevalent metabolic syndrome components and important in managing metabolic syndrome in Nigeria. Regional specific cut-offs for these components for the African population is needed.

Metabolic syndrome cardiovascular disease measures of adiposity; lipids type2 diabetes mellitus metabolic syndrome components gender African

References (25)

  1. 1 High density lipoprotein as a protective factor against coronary heart disease [DOI]
  2. 2 NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older [DOI]
  3. 3 Obesity and the Metabolic Syndrome in Developing Countries [DOI]
  4. 4 Oxidative stress and metabolic syndrome [DOI]
  5. 5 Waist-to-height ratio, a simple and practical index for assessing central fat distribution and metabolic risk in Japanese men and women [DOI]
  6. 6 Inflammation as a Link between Obesity and Metabolic Syndrome [DOI]
  7. 7 Prevalence and gender distribution of the metabolic syndrome [DOI]
  8. 8 The Metabolic Syndrome, Oxidative Stress, Environment, and Cardiovascular Disease: The Great Exploration [DOI]
  9. 9 Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. [DOI]
  10. 10 The metabolic syndrome in Africa: Current trends [DOI]
  11. 11 Unravelling the cardioprotective mechanism of action of estrogens [DOI]
  12. 12 Metabolic Syndrome in Hypertensive Patients [DOI]
  13. 13 Hypertension Is the Most Common Component of Metabolic Syndrome and the Greatest Contributor to Carotid Arteriosclerosis in Apparently Healthy Japanese Individuals [DOI]
  14. 14 The metabolic syndrome: targeting dyslipidaemia to reduce coronary risk. [DOI]
  15. 15 The role of estrogens in cardiovascular disease in the aftermath of clinical trials [DOI]
  16. 16 Urgency of reassessment of role of obesity indices for metabolic risks [DOI]
  17. 17 Hypertension and the Metabolic Syndrome [DOI]
  18. 18 SERUM TESTOSTERONE AND LIPIDS IN RELATION TO SEXUAL DYSFUNCTION IN MALES WITH METABOLIC SYNDROME AND TYPE2 DIABETES MELLITUS
  19. 19 Metabolic Alterations in Different Stages of Hypertension in an Apparently Healthy Nigerian Population [DOI]
  20. 20 Diagnostic Criteria for Metabolic Syndrome: Caucasians Versus African-Americans [DOI]
  21. 21 Impact of Dietary Intervention on Selected Biochemical Indices of Inflammation and Oxidative Stress in Nigerians with Metabolic Syndrome: A Pilot Study [DOI]
  22. 22 Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia [DOI]
  23. 23 High-density lipoprotein cholesterol levels increase with age, body mass index, blood pressure and fasting blood glucose in a rural Uygur population in China [DOI]
  24. 24 Relation between anthropometric measurements and serum lipid profile among cardio-metabolically healthy subjects: A pilot study [DOI]
  25. 25 Central Adiposity, Body Mass Index and Percent Body Fat among Bengalee Hindu Male Slum Dwellers of Dum Dum, West Bengal, India [DOI]

Cited by 11

Inhibin B Levels in Relation to Obesity Measures and Lipids in Males with Different Numbers of Metabolic Syndrome Components

D. O. Laniyan, M. A. Charles-Davies, A. A. Fasanmade, J. A. Olaniyi, O. E. Oyewole, M. O. Owolabi, J. R. Adebusuyi, O. Hassan, B. M. Ajobo, M. O. Ebesunun, K. Adigun, K. S. Akinlade, S. U. Okoli, O. G. Arinola, E. O. Agbedana · Journal of Scientific Research and Reports · 2016

Redefining the Metabolic Syndrome in Africa: A Systematic Review between 2005 and 2022

Mabel A. Charles-Davies, Olulope O. Ajayi · Dubai Diabetes and Endocrinology Journal · 2023

Showing 4 of 11 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

29

Page views

0

PDF downloads

3

Outbound clicks

11

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.